GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Aiforia Technologies PLC (OHEL:AIFORIA) » Definitions » Valuation Rank

Aiforia Technologies (OHEL:AIFORIA) Valuation Rank


View and export this data going back to 2021. Start your Free Trial

What is Aiforia Technologies Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Aiforia Technologies Valuation Rank Related Terms

Thank you for viewing the detailed overview of Aiforia Technologies's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Aiforia Technologies (OHEL:AIFORIA) Business Description

Traded in Other Exchanges
Address
Pursimiehenkatu 29-31 D, Helsinki, FIN, FI-00150
Aiforia Technologies PLC equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis beyond current capabilities, across a variety of fields from oncology to neuroscience and more.